Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SAPPHIRE CORPORATION LIMITED (BRD)

  • Business News
  • Aug. 12, 2026, 12:27 UTC
  • 2
  • 1 comments

Asset Acquisitions and Disposals: Announcement pursuant to Rule 706A of the SGX-ST Listing Manual

Market reaction Comment Full text

CENTURION CORPORATION LIMITED (OU8)

  • Business News
  • Aug. 12, 2026, 12:27 UTC
  • 2
  • 1 comments

Mandatory Cash Dividend/ Distribution:

Market reaction Comment Full text

SUNPOWER GROUP LTD. (5GD)

  • Business News
  • Aug. 12, 2026, 12:26 UTC
  • 2
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

SAPPHIRE CORPORATION LIMITED (BRD)

  • Business News
  • Aug. 12, 2026, 12:26 UTC
  • 2
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

CENTURION CORPORATION LIMITED (OU8)

  • Business News
  • Aug. 12, 2026, 12:26 UTC
  • 1
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

CENTURION CORPORATION LIMITED (OU8)

  • Business News
  • Aug. 12, 2026, 12:26 UTC
  • 1
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

SciSparc Ltd. (SPRC)

  • Business News
  • Aug. 12, 2026, 12:25 UTC
  • 1
  • 1 comments

SciSparc SPRC Notification

Market reaction Comment Full text

SCISPARC LTD. (SPRC)

  • Business News
  • Aug. 12, 2026, 12:25 UTC
  • 1
  • 1 comments

SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination

Market reaction Comment Full text

RENAISSANCE UNITED LIMITED (I11)

  • Business News
  • Aug. 12, 2026, 12:23 UTC
  • 1
  • 1 comments

Waiver: Application for Extension of Time to Hold Annual General Meeting

Market reaction Comment Full text

HO BEE LAND LIMITED (H13)

  • Business News
  • Aug. 12, 2026, 12:18 UTC
  • 2
  • 1 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Chief Executive Officer, Mr Nicholas Chua

Market reaction Comment Full text
  • Previous
  • 1129
  • 1130
  • 1131
  • 1132
  • 1133
  • Next

Search

News categories

  • Technical Exchange News(14621)
  • Event(6229)
  • SEC News(386604)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235993)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin